LARGEST PRODUCT BASKET
CHAINS & GOVT. INSTITUTIONS
650+ PRODUCTS REGISTRATIONS
SOMEONE, SOMEWHERE IS GETTING CLOSER TO
Welcome to Celon , we are one of India’s leading specialty biopharmaceutical company at the forefront of research, manufacturing and marketing of high quality formulations in niche therapy areas of Oncology and Critical Care.
Celon is a specialty focused biopharmaceutical company with core competencies in developing innovative, non-infringing, cost effective solutions. Celon adheres to global quality standards – catering to both Indian and ROW markets.
With our science and pharmaceutical expertise, we have brought a range of products from laboratory to the market and continue to do so, making medicines more accessible to people and in markets where it is most needed.
Our growing portfolio of Oncology and Critical Care products reflect our continued commitment to deliver quality treatment across the globe.
Celon – Research and Beyond
Our cutting-edge work in Novel Drug Delivery Systems include platform technologies such as Microspheres, Liposomal and Nanoparticulate formulations.
Celon – Capable and Committed
Celon works in niche therapy segments, a space that demands advanced manufacturing capabilities. To that end, we equip ourselves with the best-in-class technology and the best-in-segment practices.
LAUNCHED INDIA’S FIRST INDIGENOUS BONE MARROW TRANSPLANT RANGE
Celon Milestones
>> LAUNCHED BUSINESS OPERATIONS IN ROW MARKETS
>> LAUNCHED REVILON - OUR CRITICAL CARE FOCUSSED OFFERING WITH A VITAL PRODUCT PORTFOLIO FOR CARDIOVASCULAR AND ANAESTHESIA SEGMENT
Celon Updates


ZNZ Pharma acquires controlling stake in Celon Labs for Rs 364 crore
Corporate Video
Celon Labs is proud to be recognized for its support and contribution to the 16th Annual Conference of the Clinical Infectious Diseases Society held in Gandhinagar, Gujarat. We remain committed to advancing healthcare through innovation, collaboration, and meaningful contributions to the medical community.